Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Larisch-Bloch

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Growth Factors (Chur, Switzerland)|January 1, 1993
LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s)S Larisch-Bloch, D Sulitzeanu
Immunology Letters|July 1, 1992
Degenerative changes in the A375 melanoma line induced by transforming growth factor beta 1S Larisch-Bloch, R Yarom, D Sulitzeanu
Immunology Letters|November 1, 1990
A high molecular weight cytotoxic lymphokine in supernatants of lymphokine-activated killer cells cross-reacts with transforming growth factor betaS Larisch-Bloch, B Sterman, D Sulitzeanu
Immunology Letters|November 1, 1989
Culture supernatants of lymphokine-activated killer (LAK) cells contain a high-molecular-weight cytotoxic lymphokineS Larisch-Bloch, B Sterman, D Weiss, et al.
The Journal of Biological Chemistry|May 23, 1997
Characterization of functional domains within Smad4/DPC4M P de Caestecker, P Hemmati, S Larisch-Bloch, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 15, 2000
Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cellsS Larisch-Bloch, D Danielpour, N S Roche, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Growth Factors (Chur, Switzerland)|January 1, 1993
LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s)S Larisch-Bloch, D Sulitzeanu
Immunology Letters|July 1, 1992
Degenerative changes in the A375 melanoma line induced by transforming growth factor beta 1S Larisch-Bloch, R Yarom, D Sulitzeanu
Immunology Letters|November 1, 1990
A high molecular weight cytotoxic lymphokine in supernatants of lymphokine-activated killer cells cross-reacts with transforming growth factor betaS Larisch-Bloch, B Sterman, D Sulitzeanu
Immunology Letters|November 1, 1989
Culture supernatants of lymphokine-activated killer (LAK) cells contain a high-molecular-weight cytotoxic lymphokineS Larisch-Bloch, B Sterman, D Weiss, et al.
The Journal of Biological Chemistry|May 23, 1997
Characterization of functional domains within Smad4/DPC4M P de Caestecker, P Hemmati, S Larisch-Bloch, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 15, 2000
Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cellsS Larisch-Bloch, D Danielpour, N S Roche, et al.
Pageof 1